An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition

Gabriela Dias Noske1, Yun Song2, Rafaela Sachetto Fernandes1

  • 1Sao Carlos Institute of Physics, University of Sao Paulo, Av. Joao Dagnone, 1100 - Jardim Santa Angelina, Sao Carlos, 13563-120, Brazil.

Nature Communications
|March 21, 2023
PubMed

Insights

SARS-CoV-2 main protease (Mpro) dimerization is crucial for its activity. N-terminal processing is not essential for Mpro dimerization, but covalent inhibitors like nirmatrelvir induce dimer formation.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Virology

Background:

  • The SARS-CoV-2 main protease (Mpro) is essential for viral replication, mediating polyprotein cleavage.
  • Mpro self-processing (maturation) is critical for its dimerization and enzymatic activity.
  • Understanding Mpro's structural dynamics and dimerization mechanisms is key for antiviral drug development.

Purpose of the Study:

  • To investigate the role of N-terminal cleavage in SARS-CoV-2 Mpro dimerization and activity.
  • To elucidate the structural basis of Mpro oligomerization in solution.
  • To analyze the impact of different inhibitor classes on Mpro oligomeric states.

Main Methods:

  • Native mass spectrometry was employed to analyze Mpro oligomeric states in solution.
  • Cryo-electron microscopy (cryo-EM) provided high-resolution structural insights into N-terminal cleavage.
  • Inhibitor binding assays were performed to assess their effects on Mpro dimerization.

Main Results:

  • Native mass spectrometry revealed mixed oligomeric states of cleaved and uncleaved Mpro, indicating N-terminal processing is not critical for dimerization.
  • A 3.5 Å cryo-EM structure detailed Mpro N-terminal cleavage in a solution-based context.
  • Non-covalent inhibitors (e.g., MAT-POS-e194df51-1) inhibited dimerization, while covalent inhibitors (e.g., nirmatrelvir) promoted monomer-to-dimer conversion.

Conclusions:

  • SARS-CoV-2 Mpro dimerization is primarily driven by induced fit mechanisms upon covalent substrate processing, not solely by N-terminal self-cleavage.
  • Covalent inhibitors can stabilize the active dimeric form of Mpro.
  • These findings offer insights into Mpro's mechanism of action and potential therapeutic strategies targeting its dimerization.

Related Concept Videos

Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
48
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.8K
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
827
Protein Complex Assembly02:41

Protein Complex Assembly

Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
10.7K